Enteral Nutrition and Amino Acid Absorption
Not Applicable
Completed
- Conditions
- Malabsorption
- Interventions
- Dietary Supplement: Enteral nutrition
- Registration Number
- NCT02590120
- Lead Sponsor
- Société des Produits Nestlé (SPN)
- Brief Summary
The purpose of this study is to evaluate amino acid absorption with two different type of proteins.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
- Patient with gastrointestinal disorder : citrulline plasma concentration < 20 µmol/L and/or xylose plasma concentration < 1,7 mmol/L
- Patient under enteral nutrition at home
- Patient already receiving 1 L by day
Exclusion Criteria
- Obese patient BMI > 30
- Diabetes
- Renal or liver failure
- Glucocorticoids treatment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Enteral nutrition product : product A Enteral nutrition Administration during 16 hours. Enteral nutrition product : product B Enteral nutrition Administration during 16 hours.
- Primary Outcome Measures
Name Time Method Amino acid absorption profile 48 hours Area under the curve of amino acid plasma concentration
- Secondary Outcome Measures
Name Time Method Insulinemia evolution 48 hours Insulinemia dosage
Nutritional status 48 hours Retinol Binding Protein and Transthyretin dosage
Tolerance 48 hours Description and occurence of adverse events
Essentials amino acid absorption 48 hours Area under the curve of plasma concentration
Link between amino acid and insuline 48 hours Correlation coefficient
Trial Locations
- Locations (1)
CHU de Lille
🇫🇷Lille, France